Skip to Content
MilliporeSigma
  • Atopic dermatitis induced by systemic immunosupression with tacrolimus--case report.

Atopic dermatitis induced by systemic immunosupression with tacrolimus--case report.

European annals of allergy and clinical immunology (2013-07-19)
R S Bumbacea, I Ghiordanescu
ABSTRACT

Type I hypersensitivity reactions have been described after solid organ transplantation despite T cell targeted immunosuppressive therapy. There are several reports of food allergy, asthma and eosinophilic colitis in pediatric transplant recipients under Tacrolimus immunosuppression, but not Cyclosporine A. We present the case of a 6 year old patient that developed de novo atopic dermatitis, eosinophilia and high levels of total IgE under systemic treatment with tacrolimus.

MATERIALS
Product Number
Brand
Product Description

Supelco
Tacrolimus solution, 1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material, Cerilliant®